Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Changing Prevalence of Potential Mediators of Aminoquinoline, Antifolate, and Artemisinin Resistance Across Uganda

The Journal of Infectious Diseases(2020)10.1093/infdis/jiaa687Source: DataRank Database

Changing Prevalence of Potential Mediators of Aminoquinoline, Antifolate, and Artemisinin Resistance Across Uganda is a research paper published in The Journal of Infectious Diseases (2020). On theSindex it has a DataRank of 0. It has been cited 225 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access225 citations

Download PDF

Cite:

Linked data & code

bioproject gen

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 22.10)OA: bronzeTopics (110)Linked Datasets (25)DataCite Reuse (25)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Melissa D. Conrad ORCID,Özkan Aydemir ORCID,Marvin Duvalsaint,Jennifer Legac,Elias Duarte ORCID

Live enrichment

PubMed:33146722 PMC:PMC8006419 OpenAlex:https://openalex.org/W3095596738

National Institutes of Health

Grant: R01AI075045

National Institutes of Health

Grant: U19AI089674

National Institutes of Health

Grant: R01AI139520

FIC NIH HHS

Grant: K01 TW010868

NIAID NIH HHS

Grant: T32 AI060537

National Institutes of Health

Grant: 1R01AI139520-01

Tracking the flow of malaria parasites and drug resistance within the DRC and across its borders

National Institutes of Health

Grant: 2R01AI075045-11A1

Resistance of Malaria Parasites to Artemisinin-Based Combination Therapies in Uganda

FWCI

22.10

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

bronzeLicense: OUP Standard Publication Reuse

journalhttps://academic.oup.com/jid/article-pdf/223/6/985/36785277/jiaa687.pdf

publisherhttps://academic.oup.com/jid/article-pdf/223/6/985/36785277/jiaa687.pdf

publisherhttp://academic.oup.com/jid/advance-article-pdf/doi/10.1093/infdis/jiaa687/36094199/jiaa687.pdf

publisherhttp://academic.oup.com/jid/article-pdf/223/6/985/36785277/jiaa687.pdf

journalhttps://doi.org/10.1093/infdis/jiaa687

Fields of Study

Malaria Research and ControlPharmaceutical Quality and CounterfeitingParasites and Host Interactions0302 clinical medicine03 medical and health sciencesAminoquinolinesAntimalarialsArtemisininsDrug ResistanceFemaleFolic Acid AntagonistsHumansMalaria, FalciparumPlasmodium falciparumPregnancyPrevalenceUganda

MeSH Terms

AminoquinolinesAntimalarialsDrug ResistanceFemaleFolic Acid AntagonistsHumansPlasmodium falciparumPregnancyUgandaPrevalenceMalaria, FalciparumArtemisinins

Keywords

AntifolateArtemisininDrug resistanceMedicineMalariaPharmacologyEnvironmental healthTraditional medicineBiologyPlasmodium falciparumInternal medicineImmunologyMicrobiologyChemotherapyUgandaPfdhfrPfdhpsPfcrtPfmdr1Pfk13Malaria (rcdc)Drug Resistance (mesh)11 Medical and Health Sciences (for)Medical and Health SciencesArtemisinins (mesh)PregnancyAminoquinolines (mesh)31 Biological sciences (for-2020)Antimalarials (mesh)PrevalenceMalaria, Falciparum32 Biomedical and Clinical Sciences (for-2020)Folic Acid Antagonists (mesh)Humans (mesh)3 Good Health and Well Being (sdg)Biological SciencesPrevalence (mesh)Artemisinins06 Biological Sciences (for)Infection (hrcs-hc)Infectious DiseasesMedical Microbiology5.1 PharmaceuticalsPlasmodium falciparum (mesh)AminoquinolinesFemaleUganda (mesh)InfectionFalciparumClinical SciencesFalciparum (mesh)610Antimicrobial Resistance (rcdc)Emerging Infectious Diseases (rcdc)Rare Diseases (rcdc)AntimalarialsRare Diseases5.1 Pharmaceuticals (hrcs-rac)42 Health sciences (for-2020)BiodefenseGeneticsParasitic DiseasesHumans3207 Medical Microbiology (for-2020)Biodefense (rcdc)3202 Clinical Sciences (for-2020)Biomedical and Clinical SciencesGenetics (rcdc)Health sciencesVector-Borne Diseases (rcdc)Vector-Borne DiseasesOrphan DrugEmerging Infectious DiseasesGood Health and Well BeingPregnancy (mesh)Infectious Diseases (rcdc)Female (mesh)Microbiology (science-metrix)Orphan Drug (rcdc)Folic Acid AntagonistsAntimicrobial Resistance

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Additional file 1 of Molecular surveillance for operationally relevant genetic polymorphisms in Plasmodium falciparum in Southern Chad, 2016–2017

10.6084/m9.figshare.19351560.v1figshare

Additional file 1 of Molecular surveillance for operationally relevant genetic polymorphisms in Plasmodium falciparum in Southern Chad, 2016–2017

10.6084/m9.figshare.19351560figshare

Additional file 2 of Molecular surveillance for operationally relevant genetic polymorphisms in Plasmodium falciparum in Southern Chad, 2016–2017

10.6084/m9.figshare.19351563.v1figshare

Additional file 2 of Molecular surveillance for operationally relevant genetic polymorphisms in Plasmodium falciparum in Southern Chad, 2016–2017

10.6084/m9.figshare.19351563figshare

Additional file 1 of Temporal trends in molecular markers of drug resistance in Plasmodium falciparum in human blood and profiles of corresponding resistant markers in mosquito oocysts in Asembo, western Kenya

10.6084/m9.figshare.21102296.v1figshare

10.6084/m9.figshare.21102296figshare

Additional file 2 of Temporal trends in molecular markers of drug resistance in Plasmodium falciparum in human blood and profiles of corresponding resistant markers in mosquito oocysts in Asembo, western Kenya

10.6084/m9.figshare.21102299.v1figshare

10.6084/m9.figshare.21102299figshare

Additional file 3 of Temporal trends in molecular markers of drug resistance in Plasmodium falciparum in human blood and profiles of corresponding resistant markers in mosquito oocysts in Asembo, western Kenya

10.6084/m9.figshare.21102302.v1figshare

10.6084/m9.figshare.21102302figshare

Additional file 1 of Assessment of artemisinin tolerance in Plasmodium falciparum clinical isolates in children with uncomplicated malaria in Ghana

10.6084/m9.figshare.22598767.v1figshare

Additional file 1 of Assessment of artemisinin tolerance in Plasmodium falciparum clinical isolates in children with uncomplicated malaria in Ghana

10.6084/m9.figshare.22598767figshare

Additional file 1 of Pharmacopeial quality of artemether–lumefantrine anti-malarial agents in Uganda

10.6084/m9.figshare.23239955.v1figshare

Additional file 1 of Pharmacopeial quality of artemether–lumefantrine anti-malarial agents in Uganda

10.6084/m9.figshare.23239955figshare

Additional file 2 of Pharmacopeial quality of artemether–lumefantrine anti-malarial agents in Uganda

10.6084/m9.figshare.23239958.v1figshare

Additional file 2 of Pharmacopeial quality of artemether–lumefantrine anti-malarial agents in Uganda

10.6084/m9.figshare.23239958figshare

Additional file 1 of Healthcare provider and drug dispenser knowledge and adherence to guidelines for the case management of malaria in pregnancy in the context of multiple first-line artemisinin-based combination therapy in western Kenya

10.6084/m9.figshare.24104336.v1figshare

10.6084/m9.figshare.24104336figshare

Additional file 1 of Seasonal malaria chemoprevention in a context of high presumed sulfadoxine-pyrimethamine resistance: malaria morbidity and molecular drug resistance profiles in South Sudan

10.6084/m9.figshare.24547027.v1figshare

Additional file 1 of Seasonal malaria chemoprevention in a context of high presumed sulfadoxine-pyrimethamine resistance: malaria morbidity and molecular drug resistance profiles in South Sudan

10.6084/m9.figshare.24547027figshare